PPP2R3C gene variants cause syndromic 46,XY gonadal dysgenesis and impaired spermatogenesis in humans.


Journal

European journal of endocrinology
ISSN: 1479-683X
Titre abrégé: Eur J Endocrinol
Pays: England
ID NLM: 9423848

Informations de publication

Date de publication:
01 May 2019
Historique:
received: 29 01 2019
accepted: 20 03 2019
pubmed: 21 3 2019
medline: 24 5 2019
entrez: 21 3 2019
Statut: ppublish

Résumé

Context Most of the knowledge on the factors involved in human sexual development stems from studies of rare cases with disorders of sex development. Here, we have described a novel 46, XY complete gonadal dysgenesis syndrome caused by homozygous variants in PPP2R3C gene. This gene encodes B″gamma regulatory subunit of the protein phosphatase 2A (PP2A), which is a serine/threonine phosphatase involved in the phospho-regulation processes of most mammalian cell types. PPP2R3C gene is most abundantly expressed in testis in humans, while its function was hitherto unknown. Patients and methods Four girls from four unrelated families with 46, XY complete gonadal dysgenesis were studied using exome or Sanger sequencing of PPP2R3C gene. In total, four patients and their heterozygous parents were investigated for clinical, laboratory, immunohistochemical and molecular characteristics. Results We have identified three different homozygous PPP2R3C variants, c.308T>C (p.L103P), c.578T>C (p.L193S) and c.1049T>C (p.F350S), in four girls with 46, XY complete gonadal dysgenesis. Patients also manifested a unique syndrome of extragonadal anomalies, including typical facial gestalt, low birth weight, myopathy, rod and cone dystrophy, anal atresia, omphalocele, sensorineural hearing loss, dry and scaly skin, skeletal abnormalities, renal agenesis and neuromotor delay. We have shown a decreased SOX9-Phospho protein expression in the dysgenetic gonads of the patients with homozygous PPP2R3C variants suggesting impaired SOX9 signaling in the pathogenesis of gonadal dysgenesis. Heterozygous males presented with abnormal sperm morphology and impaired fertility. Conclusion Our findings suggest that PPP2R3C protein is involved in the ontogeny of multiple organs, especially critical for testis development and spermatogenesis. PPPR3C provides insight into pathophysiology, as well as emerging as a potential therapeutic target for male infertility.

Identifiants

pubmed: 30893644
doi: 10.1530/EJE-19-0067
pii: EJE-19-0067.R1
doi:
pii:

Substances chimiques

PPP2R3C protein, human 0
SOX9 Transcription Factor 0
SOX9 protein, human 0
Protein Phosphatase 2 EC 3.1.3.16

Types de publication

Case Reports Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

291-309

Auteurs

Tulay Guran (T)

Department of Paediatric Endocrinology and Diabetes, Marmara University.

Gozde Yesil (G)

Department of Genetics, Bezm-i Alem University.

Serap Turan (S)

Department of Paediatric Endocrinology and Diabetes, Marmara University.

Zeynep Atay (Z)

Department of Paediatric Endocrinology and Diabetes, Medipol University.

Emine Bozkurtlar (E)

Department of Pathology, Marmara University, School of Medicine, Istanbul, Turkey.

AghaRza Aghayev (A)

Department of Medical Genetics, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey.

Sinem Gul (S)

Department of Molecular Biology and Genetics, Gebze Technical University, Kocaeli, Turkey.

Ilker Tinay (I)

Department of Urology, Marmara University, School of Medicine, Istanbul, Turkey.

Basak Aru (B)

Department of Immunology, Yeditepe University, Faculty of Medicine, Istanbul, Turkey.

Sema Arslan (S)

Department of Biochemistry, Genetic and Metabolic Diseases Research and Investigation Center.

M Kutay Koroglu (MK)

Department of Histology and Embryology, Marmara University, School of Medicine, Istanbul, Turkey.

Feriha Ercan (F)

Department of Histology and Embryology, Marmara University, School of Medicine, Istanbul, Turkey.

Gulderen Y Demirel (GY)

Department of Immunology, Yeditepe University, Faculty of Medicine, Istanbul, Turkey.

Funda S Eren (FS)

Department of Pathology, Marmara University, School of Medicine, Istanbul, Turkey.

Betul Karademir (B)

Department of Biochemistry, Genetic and Metabolic Diseases Research and Investigation Center.

Abdullah Bereket (A)

Department of Paediatric Endocrinology and Diabetes, Marmara University.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH